Guide Therapeutics, Inc. — Form D/A

Guide Therapeutics, Inc. of ATLANTA, GA, a company, filed a Form D amendment with the SEC on 2020-01-13. The offering totals $8.0M, of which $8.0M was reported sold. Industry: Other Technology.

Offering

• Filed: 2020-01-13
• Form: D/A
• Accession: 0001769132-20-000003
• Industry: Other Technology
• Exemptions: 06b
• Total offering: $8.0M
• Amount sold: $8.0M
• Investors: 2
• Date of first sale: 2019-02-15
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-333816

Issuer

• Name: Guide Therapeutics, Inc.
• CIK: 0001769132
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2018
• Address: 308 NORTHYARDS BLVD. Suite B, NW, ATLANTA, GA, 30013
• Phone: 404-937-3801

Officers, directors & promoters (14)

Other filings by this issuer (3)

More

• CIK 1769132 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search